U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
117211117211Orthostatic Hypotension Treatment on Rehab UnitActive, not recruitingNo Results AvailableOrthostatic Hypotension|FallsOther: Medication review|Dietary Supplement: Nutrition/Salt intake|Other: Education|Other: Exercise|Drug: Drughttps://ClinicalTrials.gov/show/NCT01030874
117212117212Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"RecruitingNo Results AvailableAutoantibody Positive|Non-diabetic Relatives at Risk for Type 1 Diabetes|High Risk|Impaired Glucose ToleranceDrug: Teplizumabhttps://ClinicalTrials.gov/show/NCT01030861
117213117213Time-dependent Improvement of Functional Outcome Following LCS Rotating Platform TKRActive, not recruitingNo Results AvailableOsteoarthritis|Total Knee ReplacementDevice: Total Knee Replacement (LCS rotating platform)https://ClinicalTrials.gov/show/NCT01030848
117214117214Screening Protocol for the Evaluation of Research Participants at the Maryland Psychiatric Research Center (MPRC)CompletedNo Results AvailableSubstance Use Disordershttps://ClinicalTrials.gov/show/NCT01030835
117215117215Booster and Catch-up Vaccination With Vaccine GSK1024850ACompletedNo Results AvailableStreptococcus Pneumoniae|Pneumococcal DiseaseBiological: Pneumococcal vaccine GSK1024850A|Biological: Pneumococcal vaccine GSK1024850Ahttps://ClinicalTrials.gov/show/NCT01030822
117216117216Trial of a Treatment Algorithm for the Management of Crohn's DiseaseCompletedNo Results AvailableCrohn's DiseaseOther: Treatment Algorithm for Crohn's Diseasehttps://ClinicalTrials.gov/show/NCT01030809
117217117217Quitting Caffeine for Better Glucose MetabolismCompletedNo Results AvailableDiabetes Mellitus, Type 2Behavioral: Caffeine abstinencehttps://ClinicalTrials.gov/show/NCT01030796
117218117218A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell CarcinomaCompletedNo Results AvailableAdvanced Renal Cell CarcinomaDrug: tivozanib (AV-951)|Drug: Sorafenibhttps://ClinicalTrials.gov/show/NCT01030783
117219117219Preoperative Intravitreal Ranibizumab for Persistent Diabetic Vitreous Haemorrhage:Active, not recruitingNo Results AvailableDiabetes ComplicationsDrug: Ranibizumab|Drug: 0.9% Sodium Chloridehttps://ClinicalTrials.gov/show/NCT01030770
117220117220Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Metastatic Tumors to the LiverTerminatedHas ResultsLiver CancerRadiation: Tomotherapy treatmenthttps://ClinicalTrials.gov/show/NCT01030757
117221117221Evaluation of the Gestational Diabetes Self-Management Education Program and Quality Improvement PlanTerminatedNo Results AvailableGestational Diabeteshttps://ClinicalTrials.gov/show/NCT01030744
117222117222Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal DiseaseCompletedNo Results AvailableStaphylococcal Skin Infections|Streptococcal InfectionsDrug: Ceftobiprolehttps://ClinicalTrials.gov/show/NCT01030731
117223117223Rollover Study of BMS-354825 in Patients With CML and Ph+ALLCompletedHas ResultsChronic Myelogenous Leukemia|Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaDrug: dasatinibhttps://ClinicalTrials.gov/show/NCT01030718
117224117224Common Sensing and Right Ventricular Automatic Capture (COGNATE)CompletedNo Results AvailableBradycardia|Chronotropic Incompetencehttps://ClinicalTrials.gov/show/NCT01030705
117225117225Rivastigmine and Huperzine A as Treatments for Cocaine DependenceCompletedNo Results AvailableCocaine Dependence|Cocaine Addiction|Cocaine Abuse|Substance AbuseDrug: Placebo|Drug: Rivastigmine 3 mg|Drug: Huperzine A 0.4 mg|Drug: Rivastigmine 6 mg|Drug: Huperzine A 0.8 mghttps://ClinicalTrials.gov/show/NCT01030692
117226117226Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes MellitusCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: CKD-501 0.5mg|Drug: CKD-501 1mg|Drug: CKD-501 2mg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01030679
117227117227Effect of Postsurgical Systemic Doxycycline After Regenerative Periodontal TherapyTerminatedHas ResultsPeriodontitisDrug: Doxycycline|Drug: Placebo|Procedure: modified/simplified papilla preservation flap; scaling|Biological: Prefgel/Emdogain|Drug: 0.12% chlorhexidine gluconate solution|Drug: Ibuprofen 400 mg (if necessary)|Drug: 1% chlorhexidine gluconate gel (if necessary)https://ClinicalTrials.gov/show/NCT01030666
117228117228Pharmacokinetics of Voriconazole in Obese SubjectsCompletedNo Results AvailableHealthyDrug: Voriconazolehttps://ClinicalTrials.gov/show/NCT01030653
117229117229Study To Assess Changes In The Number Of Nerves In The Skin At The Site Where Where Tanezumab Is InjectedCompletedNo Results AvailableOsteoarthritis Pain|Chronic Low Back Pain|Pain Due to Interstitial CystitisOther: placebo|Biological: tanezumabhttps://ClinicalTrials.gov/show/NCT01030640
117230117230Treatment Approaches to PreeclampsiaCompletedNo Results AvailablePreeclampsiaDevice: Springfusor infusion pumphttps://ClinicalTrials.gov/show/NCT01030627
117231117231Dexamethasone Improves Postoperative Symptoms After Laparoscopic CholecystectomyCompletedNo Results AvailablePostoperative Nausea and Vomiting|Postoperative Pain|Postoperative FatigueDrug: Dexamethasone|Drug: placebohttps://ClinicalTrials.gov/show/NCT01030614
117232117232Analysis of the Effect of Intravitreal Dexamethasone Injection on Diabetic Macular Edema After Cataract Surgery (IDDMECS)CompletedNo Results AvailableDiabetes|Macular Edema|PseudophakiaDrug: Dexamethasone sodium phosphatehttps://ClinicalTrials.gov/show/NCT01030601
117233117233[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT01030588
117234117234Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)CompletedNo Results AvailableInfant, Newborn|Infant, Low Birth Weight|Infant, Small for Gestational Age|Infant, Premature|Retinopathy of Prematurity|Bronchopulmonary Dysplasia (BPD)Drug: Inositol lower volume|Drug: Inositol mid-level volume|Drug: Inositol high volume|Drug: Placebo low volumehttps://ClinicalTrials.gov/show/NCT01030575
117235117235Immunogenicity of Off-Schedule Dosing of HPV VaccineRecruitingNo Results AvailablePapilloma Viral Infectionhttps://ClinicalTrials.gov/show/NCT01030562
117236117236Latin American Multicenter Cardiovascular Magnetic Resonance Reference StudyCompletedNo Results AvailableHealthyhttps://ClinicalTrials.gov/show/NCT01030549
117237117237Safety Study of CAT-8015 to Treat Advanced B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia (NHL or CLL)CompletedNo Results AvailableNon-Hodgkin Lymphoma|Chronic Lymphocytic LeukemiaDrug: CAT-8015 Immunotoxin (Moxetumomab Pasudotox)https://ClinicalTrials.gov/show/NCT01030536
117238117238Study on ASTRA TECH Implant System, Short Implants (OsseoSpeedâ„¢) Compared to Standard Length Implants (OsseoSpeedâ„¢) With Bone SubstitutionActive, not recruitingNo Results AvailableJaw, Edentulous, PartiallyDevice: ASTRA TECH Implant System, OsseoSpeedâ„¢ 4.0 S (length: 6 mm)|Device: ASTRA TECH Implant System, OsseoSpeedâ„¢ implants (lengths: 11, 13, 15 mm)https://ClinicalTrials.gov/show/NCT01030523
117239117239Study of Rocuronium Onset Time According to Remifentanil InfusionCompletedNo Results AvailableAnesthesiaDrug: the order of drug administrationhttps://ClinicalTrials.gov/show/NCT01030510
117240117240Detection of Cervical Lymph Node Metastases With a High-Resolution Positron Emission Tomography (PET) Imaging SystemCompletedNo Results AvailableHead and Neck Cancerhttps://ClinicalTrials.gov/show/NCT01030497

* Görseller ve İçerik tekif hakkına sahip olabilir